Insights

Innovative Technology CytoSeek's focus on cell membrane augmentation technology and artificial membrane-binding proteins positions it as a pioneer in next-generation cell therapies, creating opportunities for collaboration with biotech firms seeking advanced therapeutic platforms.

Strategic Partnerships Active collaborations with universities like Birmingham and Bristol indicate openness to partnership and licensing deals, making CytoSeek a strong candidate for joint development ventures in cell therapy innovation.

Funding & Growth With $5 million in funding and recent seed investments, CytoSeek demonstrates investor confidence and financial stability, providing a solid foundation for growth and potential strategic acquisitions or licensing arrangements.

Market Focus CytoSeek's targeted development of therapies against solid tumors aligns with a growing market need, creating opportunities for medical device and pharma companies interested in expanding their oncology portfolios.

Recent Leadership The appointment of Kevin Brady as Vice President of Preclinical Development and CEO Carolyn Porter highlights strong leadership targeting clinical translation, which is attractive for partners interested in combined scientific and commercial success.

CytoSeek Tech Stack

CytoSeek uses 8 technology products and services including Amazon Web Services, Amazon S3, Amazon CloudFront, and more. Explore CytoSeek's tech stack below.

Amazon Web Services

Cloud Hosting

Amazon S3

Content Delivery Network

Amazon CloudFront

Content Delivery Network

Squarespace

Content Management System

Google Workspace

Google Fonts API

Font Scripts

Microsoft Office

Office Suites

Google

Search Engines

CytoSeek Email Formats	Example	Percentage
First@cytoseek.uk	John@cytoseek.uk	100%

CytoSeek Email Formats

Example

Percentage

First@cytoseek.uk

John@cytoseek.uk

100%

Frequently Asked Questions

Where is CytoSeek's headquarters located?

CytoSeek's main headquarters is located at Bristol, England United Kingdom. The company has employees across 1 continents, including Europe.

What is CytoSeek's official website and social media links?

CytoSeek's official website is cytoseek.uk and has social profiles on LinkedIn Crunchbase.

What is CytoSeek's NAICS code?

CytoSeek's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does CytoSeek have currently?

As of June 2026, CytoSeek has approximately 2 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: B. C.Senior Researcher: T. G.Senior Protein Scientist: J. B.. Explore CytoSeek's employee directory with LeadIQ.

What industry does CytoSeek belong to?

CytoSeek operates in the Research Services industry.

What technology does CytoSeek use?

CytoSeek's tech stack includes Amazon Web ServicesAmazon S3Amazon CloudFrontSquarespaceGoogle WorkspaceGoogle Fonts APIMicrosoft OfficeGoogle.

What is CytoSeek's email format?

CytoSeek's email format typically follows the pattern of First@cytoseek.uk. Find more CytoSeek email formats with LeadIQ.

How much funding has CytoSeek raised to date?

As of June 2026, CytoSeek has raised $5M in funding. The last funding round occurred on Mar 16, 2021 for $5M.

When was CytoSeek founded?

CytoSeek was founded in 2017.

CytoSeek

Q: What is CytoSeek's official website and social media links?

CytoSeek's official website is cytoseek.uk. CytoSeek has social profiles on LinkedIn.

Q: How many employees does CytoSeek have currently?

CytoSeek has approximately 2 employees.

Q: What technology does CytoSeek use?

CytoSeek's tech stack includes Amazon S3, Modernizr, Google, Amazon Web Services, Microsoft Office.

Q: What is CytoSeek's NAICS code?

CytoSeek's NAICS code is 5417 (Scientific Research and Development Services).

Research ServicesEngland, United Kingdom2-10 Employees

CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies.

Our novel cell membrane augmentation technology enables us to add new functionalities to various therapeutic cells. 

CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.

Insights

Similar companies to CytoSeek

Kernal Biologics

Future Positive Capital

Eligo Bioscience

Lofta

NeuCyte

Integra LifeSciences

CytoSeek Tech Stack

Media & News

Cytoseek hires Kevin Brady as Vice President of Preclinical Development.

Cytoseek received financing of $4.84M in Seed on Mar 1st '21.

Cytoseek is developing cell therapies to treat solid tumours.

Cytoseek partners with University of Birmingham.

Cytoseek is developing class of chimeric antigen receptor -T cell that can attack solid tumours.

Cytoseek hired Carolyn Porter as chief executive officer on Jan 3rd '20.

Cytoseek is developing next generation cell therapies.

CytoSeek's Email Address Formats